Gene · 1066
Papers3,256
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,256
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer. | Research (Wash D C) | 2026 | 41743623 | PubTator, text mining | PubMed |
| CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability. | J Pharm Anal | 2026 | 41732321 | PubTator, text mining | PubMed |
| A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report. | Cancer Manag Res | 2026 | 41726170 | PubTator, text mining | PubMed |
| Selective Near-Infrared Fluorescent Chemosensors for Human Carboxylesterase 1 Activity. | Anal Chem | 2026 | 41725560 | PubTator, text mining | PubMed |
| Dual-gold nanoprobe system enables highly sensitive SERS detection of glycosylated CEs1 in HepG-2 cell culture supernatant. | Talanta | 2026 | 41722413 | PubTator, text mining | PubMed |
| The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approach. | Br J Clin Pharmacol | 2026 | 41721490 | PubTator, text mining | PubMed |
| DeCAF defines clinical fibroblast subtypes and multidimensional tumor-stroma crosstalk shaping prognosis and immunotherapy response. | Cell Rep Med | 2026 | 41707654 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Mechanism of Xiehuo Pingtu San in Treating Thyroid Eye Disease Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation. | Int J Endocrinol | 2026 | 41694764 | PubTator, text mining | PubMed |
| Identification of disulfidptosis-related genes in immunity and immunotherapy in diabetic foot ulcer. | Ann Med Surg (Lond) | 2026 | 41675755 | PubTator, text mining | PubMed |
| Pharmacological profiles and mechanism of action of remimazolam for ICU sedation. | J Intensive Care | 2026 | 41673886 | PubTator, text mining | PubMed |
| Detoxification of T-2 toxin in human chondrocytes due to its hydroxylation by carboxylesterases and arylacetamide deacetylase in the liver. | Food Chem Toxicol | 2026 | 41672295 | PubTator, text mining | PubMed |
| Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions. | J Stroke | 2026 | 41656635 | PubTator, text mining | PubMed |
| Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort. | Sci Rep | 2026 | 41652091 | PubTator, text mining | PubMed |
| AP2/ERF transcription factors regulate the biosynthesis of terpenoids, phenolics, and alkaloids in plants. | Hortic Res | 2026 | 41647723 | PubTator, text mining | PubMed |
| Transcriptomic profile and gene expression of human breast cancer cell lines treated with herbal extract of clinacanthus nutans leaves. | J Asian Nat Prod Res | 2026 | 41643046 | PubTator, text mining | PubMed |
| Delayed emergence with remimazolam after laparoscopic subsegmental hepatectomy including the intermittent pringle maneuver in a patient with preserved liver function. | JA Clin Rep | 2026 | 41639331 | PubTator, text mining | PubMed |
| Integrating multi-structure covalent docking with machine-learning consensus scoring enhances potency ranking of human acetylcholinesterase inhibitors. | Brief Bioinform | 2026 | 41632595 | PubTator, text mining | PubMed |
| Ester Prodrug NLRP3 Inflammasome Inhibitor NT-0796 is Brain Active due to Activation by Local Expression of Carboxylesterase-1. | ACS Chem Neurosci | 2026 | 41586719 | PubTator, text mining | PubMed |
| Lingual Dyskinesia Developing after the First Dose of Methylphenidate Treatment in a Child with Neurodevelopmental Disorders: Genetic Predispositions. | Clin Psychopharmacol Neurosci | 2026 | 41582482 | PubTator, text mining | PubMed |
| Methamphetamine-Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management. | Pulm Circ | 2026 | 41567751 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1066/papers?page=4